Please provide your email address to receive an email when new articles are posted on . Combining lifileucel plus pembrolizumab conferred a complete response in nearly one-third of patients with ...
Patients with chronic lymphocytic leukemia treated with Imbruvica plus Venclexta demonstrated a healthy immune profile over time in addition to reduction in CLL disease burden. Firstline treatment ...
The FDA approval of nivolumab plus cisplatin and gemcitabine marks the first concurrent immunotherapy-chemotherapy combination for the population. The trial showed the combination significantly ...
Final overall survival data were presented at the European Lung Cancer Congress in Copenhagen, Denmark. The benefits of adding cemiplimab (Libtayo, Regeneron) to platinum-doublet chemotherapy in the ...
The benefit obtained from Keytruda plus chemotherapy in patients with persistent, recurrent or metastatic cervical cancer occurred regardless of whether they also received Avastin. Patients with ...
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...
You'll notice there are a lot of options for dogs especially, but the one you choose depends on what size your dog is. So, if you have a small dog, you might go for this one that's 43 percent off; if ...
Influence of Nucleophosmin (NPM1) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration Patients age ≥60 years with newly diagnosed, any stage, cHL were treated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback